Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | EP300 | Q09472 | 1/20 | 0.39 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29728434 | 1.00 | ATM (0.55) | ATMALDH1A1GAAKDM4EPOLB | |
| SCHEMBL28817922 | 0.83 | POLB (0.38) | ATMALDH1A1GAAKDM4EPOLB | |
| SCHEMBL28616193 | 0.82 | POLB (0.42) | ATMALDH1A1KDM4EPOLBTSHR | |
| SCHEMBL19457040 | 0.81 | ALDH1A1 (0.42) | ATMALDH1A1GAAKDM4EPOLB | |
| SCHEMBL950165 | 0.79 | ALDH1A1 (0.69) | ATMALDH1A1GAAKDM4EPOLB | |
| SCHEMBL28802533 | 0.77 | ALDH1A1 (0.49) | ATMALDH1A1GAAKDM4EPOLB | |
| SCHEMBL15181537 | 0.75 | ALDH1A1 (0.50) | ATMALDH1A1GAAKDM4EPOLB | |
| SCHEMBL9043362 | 0.75 | ALDH1A1 (0.50) | ATMALDH1A1GAAKDM4EPOLB | |
| SCHEMBL28802579 | 0.72 | ATM (0.47) | ATMALDH1A1GAAKDM4EPOLB | |
| SCHEMBL951077 | 0.72 | GAA (0.50) | ATMALDH1A1GAAKDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114878727-A | Method for determining hymexazol residues in tobacco | 合肥高尔生命健康科学研究院有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-113321789-B | Four polymeric metal complex dye sensitizers containing pyrrole derivatives, and preparation method and application thereof | 湘潭大学 | 2022-05-13 | — | — | CN | claimed |
| CN-113321789-A | Four novel polymeric metal complex dye sensitizers containing pyrrole derivatives, and preparation method and application thereof | 湘潭大学 | 2021-08-31 | — | — | CN | claimed |
| CN-114878727-B | Method for determining hymexazol residues in tobacco | 合肥高尔生命健康科学研究院有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-114878727-A | Method for determining hymexazol residues in tobacco | 合肥高尔生命健康科学研究院有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-114773314-A | Biarylaminoguanidine derivative | 上海拓界生物医药科技有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-113321789-B | Four polymeric metal complex dye sensitizers containing pyrrole derivatives, and preparation method and application thereof | 湘潭大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-113321789-A | Four novel polymeric metal complex dye sensitizers containing pyrrole derivatives, and preparation method and application thereof | 湘潭大学 | 2021-08-31 | — | — | CN | disclosed |
| US-10813939-B2 | Bromodomain inhibitor as adjuvant in cancer immunotherapy | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2020-10-27 | — | — | US | disclosed |
| US-10676484-B2 | Compositions and methods for treating leukemia | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-06-09 | — | — | US | disclosed |
| US-20200148702-A1 | COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS | DANA FARBER CANCER INST INC (US) | 2020-05-14 | — | — | US | disclosed |
| US-7867949-B2 | Hydrazide compound and pesticidal use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-11 | — | — | US | disclosed |
| EP-2251336-A1 | Hydrazide compounds as intermediates of pesticides | Sumitomo Chemical Company, Limited (JP) | 2010-11-17 | — | — | EP | disclosed |
| US-20090181956-A1 | Hydrazide Compound and Pesticidal Use of the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-16 | — | — | US | disclosed |
| CN-101287721-A | Hydrazide compound and pesticidal use of the same | SUMITOMO CHEMICAL CO (JP) | 2008-10-15 | — | — | CN | disclosed |
| EP-1937664-A1 | HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | Sumitomo Chemical Company, Limited (JP) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007043677-A9 | HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL CO (JP) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007043677-A9 | HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL CO (JP) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007043677-A1 | HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-04-19 | — | — | WO | disclosed |
| WO-2007043677-A1 | HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10813939-B2 | Bromodomain inhibitor as adjuvant in cancer immunotherapy | BRDT, BRD4, BRD1 | ATM 444/4885ALDH1A1 2424/4885GAA 3709/4885 |
| US-10676484-B2 | Compositions and methods for treating leukemia | MCL1, ABL1, FLT3 | ATM 887/4885ALDH1A1 1723/4885GAA 1077/4885 |
| US-20200148702-A1 | COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS | BRPF3, EP300, BRD3 | ATM 2001/4885ALDH1A1 3670/4885GAA 2083/4885 |
| US-20090181956-A1 | Hydrazide Compound and Pesticidal Use of the Same | ACHE, DDT, CAT | ATM 4552/4885ALDH1A1 436/4885GAA 1258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.